Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study.

Takeuchi M, Kezuka T, Sugita S, Keino H, Namba K, Kaburaki T, Maruyama K, Nakai K, Hijioka K, Shibuya E, Komae K, Hori J, Ohguro N, Sonoda KH, Mizuki N, Okada AA, Ishibashi T, Goto H, Mochizuki M.

Ophthalmology. 2014 Oct;121(10):1877-84. doi: 10.1016/j.ophtha.2014.04.042. Epub 2014 Jun 18.

PMID:
24950593
2.

Multicenter study of infliximab for refractory uveoretinitis in Behçet disease.

Okada AA, Goto H, Ohno S, Mochizuki M; Ocular Behçet's Disease Research Group Of Japan..

Arch Ophthalmol. 2012 May;130(5):592-8. doi: 10.1001/archophthalmol.2011.2698.

PMID:
22652845
3.

Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.

Niccoli L, Nannini C, Benucci M, Chindamo D, Cassarà E, Salvarani C, Cimino L, Gini G, Lenzetti I, Cantini F.

Rheumatology (Oxford). 2007 Jul;46(7):1161-4. Epub 2007 May 3.

PMID:
17478466
4.

Clinical background comparison of patients with and without ocular inflammatory attacks after initiation of infliximab therapy.

Yoshida A, Kaburaki T, Okinaga K, Takamoto M, Kawashima H, Fujino Y.

Jpn J Ophthalmol. 2012 Nov;56(6):536-43. doi: 10.1007/s10384-012-0182-z. Epub 2012 Oct 2.

PMID:
23053631
5.

Clinical course of patients with Behçet's uveitis following discontinuation of infliximab therapy.

Kawaguchi T, Kawazoe Y, Kamoi K, Miyanaga M, Takase H, Sugita S, Mochizuki M.

Jpn J Ophthalmol. 2014 Jan;58(1):75-80. doi: 10.1007/s10384-013-0283-3. Epub 2013 Oct 16.

PMID:
24129677
6.

Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.

Accorinti M, Pirraglia MP, Paroli MP, Priori R, Conti F, Pivetti-Pezzi P.

Jpn J Ophthalmol. 2007 May-Jun;51(3):191-6. Epub 2007 Jun 7.

PMID:
17554481
7.

[Effects and safety of infliximab administration in refractory uveoretinitis with Behçet's disease].

Tanaka H, Sugita S, Yamada Y, Kawaguchi T, Iwanaga Y, Kamoi K, Yokota M, Takase H, Mochizuki M.

Nippon Ganka Gakkai Zasshi. 2010 Feb;114(2):87-95. Japanese.

PMID:
20187505
8.

Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.

Calvo-Río V, Blanco R, Beltrán E, Sánchez-Bursón J, Mesquida M, Adán A, Hernandez MV, Hernandez Garfella M, Valls Pascual E, Martínez-Costa L, Sellas-Fernández A, Cordero Coma M, Díaz-Llopis M, Gallego R, Salom D, García Serrano JL, Ortego N, Herreras JM, Fonollosa A, García-Aparicio AM, Maíz O, Blanco A, Torre I, Fernández-Espartero C, Jovani V, Peiteado-Lopez D, Pato E, Cruz J, Fernández-Cid C, Aurrecoechea E, García M, Caracuel MA, Montilla C, Atanes A, Hernandez FF, Insua S, González-Suárez S, Sánchez-Andrade A, Gamero F, Linares L, Romero-Bueno F, García AJ, Almodovar R, Minguez E, Carrasco Cubero C, Olive A, Vázquez J, Ruiz Moreno O, Jiménez-Zorzo F, Manero J, Muñoz Fernández S, Rueda-Gotor J, González-Gay MA.

Rheumatology (Oxford). 2014 Dec;53(12):2223-31. doi: 10.1093/rheumatology/keu266. Epub 2014 Jul 4.

PMID:
24996907
9.
10.

Health- and vision-related quality of life in patients receiving infliximab therapy for Behcet uveitis.

Sakai T, Watanabe H, Kuroyanagi K, Akiyama G, Okano K, Kohno H, Tsuneoka H.

Br J Ophthalmol. 2013 Mar;97(3):338-42. doi: 10.1136/bjophthalmol-2012-302515. Epub 2013 Jan 12.

PMID:
23314623
11.

Behçet's disease ocular attack score 24: evaluation of ocular disease activity before and after initiation of infliximab.

Kaburaki T, Namba K, Sonoda KH, Kezuka T, Keino H, Fukuhara T, Kamoi K, Nakai K, Mizuki N, Ohguro N; Ocular Behçet Disease Research Group of Japan..

Jpn J Ophthalmol. 2014 Mar;58(2):120-30. doi: 10.1007/s10384-013-0294-0. Epub 2014 Jan 31.

PMID:
24482146
12.

Long-term efficacy of infliximab on background vascular leakage in patients with Behçet's disease.

Keino H, Okada AA, Watanabe T, Taki W.

Eye (Lond). 2014 Sep;28(9):1100-6. doi: 10.1038/eye.2014.138. Epub 2014 Jun 20.

13.

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis.

Ohno S, Nakamura S, Hori S, Shimakawa M, Kawashima H, Mochizuki M, Sugita S, Ueno S, Yoshizaki K, Inaba G.

J Rheumatol. 2004 Jul;31(7):1362-8.

PMID:
15229958
14.

Intravitreal infliximab for sight-threatening relapsing uveitis in Behçet disease: a pilot study in 15 patients.

Markomichelakis N, Delicha E, Masselos S, Sfikakis PP.

Am J Ophthalmol. 2012 Sep;154(3):534-541.e1. doi: 10.1016/j.ajo.2012.03.035. Epub 2012 Jul 11.

PMID:
22789563
15.

Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behçet's disease.

Takeuchi M, Asukata Y, Kawagoe T, Ito N, Nishide T, Mizuki N.

Ocul Immunol Inflamm. 2012 Jun;20(3):193-7. doi: 10.3109/09273948.2012.665124. Epub 2012 Apr 9.

PMID:
22486264
16.

Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet's disease on infliximab therapy.

Keino H, Okada AA, Watanabe T, Taki W.

Br J Ophthalmol. 2011 Sep;95(9):1245-50. doi: 10.1136/bjo.2010.194464. Epub 2010 Dec 22.

PMID:
21183514
17.

Cataract surgery under systemic infliximab therapy in patients with refractory uveitis associated with Behcet disease.

Alfawaz A, Alrashidi S, Kalantan H, Al-Mezaine H, Abu AM.

Ann Saudi Med. 2014 Jul-Aug;34(4):328-33. doi: 10.5144/0256-4947.2014.328.

18.

Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.

Interlandi E, Leccese P, Olivieri I, Latanza L.

Clin Exp Rheumatol. 2014 Jul-Aug;32(4 Suppl 84):S58-62. Epub 2014 Jul 8.

PMID:
25005224
19.

Changes in subfoveal choroidal thickness associated with uveitis activity in patients with Behçet's disease.

Ishikawa S, Taguchi M, Muraoka T, Sakurai Y, Kanda T, Takeuchi M.

Br J Ophthalmol. 2014 Nov;98(11):1508-13. doi: 10.1136/bjophthalmol-2014-305333. Epub 2014 Jun 17.

PMID:
24939422
20.

A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behçet's disease: a comparative 4-week study.

Markomichelakis N, Delicha E, Masselos S, Fragiadaki K, Kaklamanis P, Sfikakis PP.

Rheumatology (Oxford). 2011 Mar;50(3):593-7. doi: 10.1093/rheumatology/keq366. Epub 2010 Nov 21.

PMID:
21097877

Supplemental Content

Support Center